Clinical trial
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating…
NCT00002580 · Scottish Cancer Therapy Network, Other · Completed
Key facts
| NCT number | NCT00002580 |
|---|---|
| Title | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer |
| Official title | PROTOCOL FOR THE SCOTTISH PREMENOPAUSAL CHEMO-ENDOCRINE TRIAL |
| Lead sponsor | Scottish Cancer Therapy Network, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cyclophosphamide, fluorouracil, goserelin acetate, leuprolide acetate, methotrexate, tamoxifen citrate, conventional surgery, laparoscopic surgery, oophorectomy, radiation therapy |
| Enrollment | 1,000 |
| Start date | Jun 1, 1993 |
| First posted | Mar 11, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: